Potential RNA markers of abnormal heart rhythms identified in circulating blood

Potential RNA Markers of abnormal heart rhythms identified in circulating blood
Since atrial fibrillation (AF) strongly increases the risk of stroke, it is important to detect AF as early as possible, in order to start preventive therapy. However, about one-third of AF is asymptomatic, and it is sometimes difficult to detect AF in a case with paroxysmal AF. We screened circulating microRNAs in peripheral blood, and found 4 microRNAs associated with the presence of AF. The diagnostic panel utilizing these 4 microRNAs might be useful to predict an asymptomatic and/or undiagnosed AF with a blood test. Credit: Department of Biofunctional Informatics,TMDU

Atrial fibrillation (AF) is a heart condition that causes an irregular and often rapid heart rate. It increases the risk of developing strokes, heart failure, and even dementia. Although associated with aging, high blood pressure, diabetes and heart valve problems, about one-third of patients with AF have no symptoms until they suffer a stroke. Therefore, a means of identifying or predicting AF for preventative therapy is highly desirable.

AF is associated with several factors that maintain its progression, including inflammation, electrical disturbances, and structural changes in the heart's upper chambers (the atria). Moreover, several short sequences of RNA known as microRNAs (miRNAs) are linked with AF pathology. These miRNAs after the transcription stage, and have been suggested as possible markers for some cardiovascular diseases because of their stability in the bloodstream. However, it remains unknown whether the miRNAs shown to be related to AF are suitable as predictive biomarkers of disease.

A team of researchers from Tokyo Medical and Dental University (TMDU) addressed this issue by comparing miRNA in AF patients and healthy controls, and between mice and those with a similar abnormal rhythm to AF. They showed that four miRNAs not previously associated with AF were significantly upregulated in the serum of AF patients and diseased mice, indicating their potential use as AF biomarkers. The study results were recently published in Circulation Journal.

Initially, human serum and mouse atrial tissue were screened for 733 and 672 miRNAs, respectively. These were eventually narrowed down to four by excluding non-detectable and non-specific miRNAs, and focusing on the quantification of their expression.

"One of the miRNAs, miR-214-3p, is implicated in inflammation, so we wondered whether this might be the underlying mechanism of miRNA-induced AF pathology," first author Yu Natsume says. "We compared miRNA expression with levels of a serum inflammatory factor but found no correlation suggestive of an association."

Statistical analysis of diagnostic ability showed that miR-214-3p and miR-342-5p had the highest accuracy as individual biomarkers at predicting AF, but that a combined analysis of all four miRNAs slightly improved this accuracy.

"The same two miRNAs showed increased expression in a subset of patients with intermittent AF and another subset with chronic AF," corresponding author Tetsuo Sasano says. "The increases were in comparison both with healthy controls of the same age and young healthy controls, suggesting these miRNAs may predict AF regardless of the age of the individual."

The researchers propose additional studies to determine the functional role of the identified miRNAs with respect to AF.

Explore further

MicroRNA biomarker signature identified for allergic asthma

More information: Yu Natsume et al, Combined Analysis of Human and Experimental Murine Samples Identified Novel Circulating MicroRNAs as Biomarkers for Atrial Fibrillation, Circulation Journal (2018). DOI: 10.1253/circj.CJ-17-1194
Provided by Tokyo Medical and Dental University
Citation: Potential RNA markers of abnormal heart rhythms identified in circulating blood (2018, March 19) retrieved 20 April 2021 from https://medicalxpress.com/news/2018-03-potential-rna-markers-abnormal-heart.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments